NBRI17671, a new antitumor compound, produced by Acremonium sp. CR17671

Manabu Kawada(Microbial Chemistry Research Foundation), Daishiro Ikeda(Microbial Chemistry Research Foundation)
The Journal of Antibiotics
April 9, 2010
10.1038/ja.2010.28
Cited by 9

Related Papers

Structures and biological activities of novel 4’-acetylated analogs of chrysomycins A and B
|The Journal of Antibiotics|2017|22
Pancreatic Stromal Cell-derived Oncostatin M Confers Drug Resistance to a Multi-tyrosine Kinase Inhibitor in Pancreatic Cancer Cells
|Anticancer Research|2023|4
Design and Evaluation of Eb4Mab-7-mG2a: A Dual-Action Anti-EphB4 Monoclonal Antibody for Targeted Breast Cancer Therapy
|Preprints.org|2025|0